Tackling a Global Pandemic
ABS was founded because there’s a real need for improvements in the way we approach the global heart disease problem. Current methods for treating heart disease aren’t always successful. 7.4 million people die from a heart attack every year. Several new technologies could change that and our innovative new stenting platform is one of them. We hope that human clinical trials and FDA review will show that it could reduce the need for open-heart surgery and improve the quality of life for patients suffering from heart disease.
How the ABS System Works
One of the most difficult procedures for heart surgeons is trying to place stents in branched arteries. The ABS system is designed to simplify the process and replace most open-heart surgeries with a less invasive procedure that can be performed as a day surgery.
Open-heart surgery is a stressful experience for the patient and many suffer depression after their operation. A simple day procedure would reduce their anxiety and allow them to return to their daily lives without a significant recovery period.
The method works by using a dual catheter system to place stents in both the mother and daughter vessels of a branched artery at the same time. The technology is self-aligning as well, to reduce the risk of errors and it’s simple to perform. Most cardiac surgeons will be able to perform the procedure without much training.
A Major Part of the Puzzle
The ABS system isn’t the only breakthrough we hope could aid in reducing deaths from heart disease. New technologies in the areas of Artificial Intelligence, apps, and wearable devices are also part of the solution. It’s not difficult to imagine the risk of death from a heart attack being cut in half in the next decade. Technology is allowing people to live longer and healthier lives. I think that Advanced Bifurcation Systems is a major piece of the puzzle along with these other technologies.